Pyxis Oncology Inc (PYXS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pyxis Oncology Inc   (NASDAQ: PYXS)


Pyxis Oncology Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Pyxis Oncology Inc 's ROA in the second quarter of 2026?
Pyxis Oncology Inc recorded a cumulative net loss of $-89 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -107.87%.

However, within the Healthcare sector 758 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4198, from total ROA ranking in the first quarter of 2026 at 4800.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -45.14 % -52.67 % -36.86 % -45.93 % -40.87 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -89 -82 -80 -97 -96
Return On Assets (TTM) -107.87 % -85 % -69.81 % -76.2 % -64.26 %
PYXS's Total Ranking # 4198 # 4800 # 4232 # 4213 # 4212
Total Assets (TTM) in million 68 64 92 106 123
Seq. Total Assets Change 5.12 % -29.74 % -13.34 % -14.29 % -9.31 %
Seq. Net Income Change - - - - -

PYXS's 5 Years Annual ROA >> Back to PYXS Management Effectiveness >> Compare PYXS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 351
Sector # 759
Overall # 4262

Return On Assets Statistics
High Average Low
-28.76 %
-51.84 %
-112.19 %
(Sep 30 2024)   (Jun 30 2026)





Financial Statements
Pyxis Oncology Inc 's Assets $ 68 million PYXS's Balance sheet
Pyxis Oncology Inc 's Income $ -25 million Quarterly PYXS's Income Statement
PYXS's Income by Division See PYXS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -44.73 % -9.85 % -18.7 % -29.37 % -
Total Assets in million 80 145 161 198 280
Y / Y Net Income Change - - - - -
Net Income in million -80 -77 -74 -121 -76
Annual Return On Assets -99.4 % -53.35 % -45.89 % -61.04 % -27.13 %

PYXS's 5 Years Annual ROA >> Back to PYXS Management Effectiveness >> Compare PYXS ROA to its Competitors



More Return On Assets Ratios
PYXS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PYXS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PYXS's Competitors
Subscribers only: Roa for Pyxis Oncology Inc 's Suppliers
Subscribers only: Return On Assets for PYXS's Customers

You may also want to know
PYXS's Roi PYXS's Inventory Turnover Ratio PYXS's Growth Rates PYXS's Dividend Comparisons
PYXS's Profitability Ratios PYXS's Asset Turnover Ratio PYXS's Dividend Growth
PYXS's Roe PYXS's Valuation Ratios PYXS's Financial Strength Ratios PYXS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-26T07:40:41+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.